4.34
+0(+0.00%)
Currency In USD
Address
4200 Marathon Boulevard
Austin, TX 78756
United States of America
Phone
512 215 2630
Website
Sector
Healthcare
Industry
Biotechnology
Employees
30
First IPO Date
November 11, 2011
| Name | Title | Pay | Year Born |
| Mr. Richard J. Hawkins | Founder, Chief Executive Officer & Chairman | 854,352 | 1949 |
| Ms. Lori D. Lawley CPA | Chief Financial Officer & Principal Accounting Officer | 538,229 | 1984 |
| Mr. Bradley J. Powers J.D. | Chief Compliance Officer & General Counsel | 677,078 | 1979 |
| Dr. John C. McKew Ph.D. | Chief Scientific Officer & President | 860,382 | 1964 |
| Ms. Lisa Wells Miller | Senior Director of Investor Relations | 0 | N/A |
| Dr. Pisit Pitukcheewanont FAAP, M.D. | Chief Medical Officer | 0 | N/A |
| Mr. Eddie L. Varnado M.B.A. | Corporate Controller | 0 | N/A |
| Mr. Aaron Schuchart B.B.A., CPA, M.B.A. | Chief Business Officer | 0 | 1966 |
| Ms. Alpa Parikh | Senior Vice President of CMC & Supply Management | 0 | N/A |
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare endocrine disorders. The company is headquartered in Austin, Texas.